Lakota Research International Inc, registered in Road Town, Tortola, British Virgin Islands, has acquired the ownership of 5,000,000 common shares in the capital stock of biotechnological company IRI Separation Technologies Inc. As a result of this arrangement, BVI company Lakota Research International owns and controls the amount of shares which represent 26.5 percent of the issued and outstanding share capital of the IRI Separation Technologies Inc.
The BVI company does not own or control any other securities of IRI Separation Technologies. The shares were acquired in a private transaction at a price of $0.40 per share. Lakota may acquire other shares of the Company for investment purposes.
IRI Separation Technologies is a company that specializes in the extraction, development and marketing of monoclonal and polyclonal immunoglobulin antibodies for virus and bacteria related health issues. The immunoglobulin antibodies are intended for both the general and specific antibody market and are used as a nutraceutical for human consumption. Recently the Company has arranged for a private placement of up to 1,500,000 units at a price of $0.60 per unit.